- LT-673
-
- $1.00
-
2019-12-24
- CAS:1207454-56-5
- Min. Order: 1g
- Purity: 99.99%
- Supply Ability: 200kg
|
| Product Name: | LT-673 | | Synonyms: | 3H-Pyrido[4,3,2-de]phthalazin-3-one, 5-fluoro-8-(4-fluorophenyl)-2,7,8,9-tetrahydro-9-(1-Methyl-1H-1,2,4-triazol-5-yl)-;5-fluoro-8-(4-fluorophenyl)-9-(1-Methyl-1H-1,2,4-triazol-5-yl)-8,9-dihydro-2H-pyrido[4,3,2-de]phthalazin-3(7H)-one;5-fluoro-8-(4-fluorophenyl)-2,7,8,9-tetrahydro-9-(1-methyl-1H-;5-Fluoro-8-(4-fluorophenyl)-9-(1-methyl-1H-1,2,4-triazol-5-yl)-8,9-dihydro-2H-pyrido[4,3,2-de];5-fluoro-8-(4-fluorophenyl)-9-(1-methyl-1H-1,2,4-triazol-5-yl)-2,7,8,9-tetrahydro-3H-pyrido[4,3,2-de]phthalazin-3-one;5-Fluoro-8-(4-fluorophenyl)-2,7,8,9-tetrahydro-9-(1-methyl-1H-1,2,4-triazol-5-yl)-3H-pyrido[4,3,2-de]phthalazin-3-one;TALAZ-014;Citalopram Impurity 7(Citalopram EP Impurity E)HBr | | CAS: | 1207454-56-5 | | MF: | C19H14F2N6O | | MW: | 380.35 | | EINECS: | | | Product Categories: | api | | Mol File: | 1207454-56-5.mol |  |
| | LT-673 Chemical Properties |
| density | 1.63±0.1 g/cm3(Predicted) | | pka | 10.14±0.60(Predicted) |
| | LT-673 Usage And Synthesis |
| Uses | BMN 673 is a pyrrolopyrazine derivative and anpoly (ADP-ribose) polymerase (PARP) inhibitor for patients with advanced or recurrent solid tumors such as ovarian and breast cancer. | | IC 50 | PARP2: 0.87 nM (Ki); PARP1: 1.2 nM (Ki) |
| | LT-673 Preparation Products And Raw materials |
|